Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI‐shock registry results

Abstract

TAVI seems to be a therapeutic option for patients with CS and SAS or degenerated aortic bioprosthesis in terms of both safety and efficacy at early and long-term follow-up.